Meta-analysis of Shotgun Sequencing of Gut Microbiota in Parkinson's Disease

Overview

Journal NPJ Parkinsons Dis

Date 2024 May 21

PMID 38773112

Authors

Hiroshi Nishiwaki

Jun Ueyama

Mikako Ito

Tomonari Hamaguchi

Keiichi Takimoto

Tetsuya Maeda

Kenichi Kashihara

Yoshio Tsuboi

Hiroshi Mori

Ken Kurokawa

Masahisa Katsuno

Masaaki Hirayama

Kinji Ohno

Affiliations

Soon will be listed here.

Abstract

We aimed to identify gut microbial features in Parkinson's disease (PD) across countries by meta-analyzing our fecal shotgun sequencing dataset of 94 PD patients and 73 controls in Japan with five previously reported datasets from USA, Germany, China1, China2, and Taiwan. GC-MS and LC-MS/MS assays were established to quantify fecal short-chain fatty acids (SCFAs) and fecal polyamines, respectively. α-Diversity was increased in PD across six datasets. Taxonomic analysis showed that species Akkermansia muciniphila was increased in PD, while species Roseburia intestinalis and Faecalibacterium prausnitzii were decreased in PD. Pathway analysis showed that genes in the biosyntheses of riboflavin and biotin were markedly decreased in PD after adjusting for confounding factors. Five out of six categories in carbohydrate-active enzymes (CAZymes) were decreased in PD. Metabolomic analysis of our fecal samples revealed that fecal SCFAs and polyamines were significantly decreased in PD. Genes in the riboflavin and biotin biosyntheses were positively correlated with the fecal concentrations of SCFAs and polyamines. Bacteria that accounted for the decreased riboflavin biosynthesis in Japan, the USA, and Germany were different from those in China1, China2, and Taiwan. Similarly, different bacteria accounted for decreased biotin biosynthesis in the two country groups. We postulate that decreased SCFAs and polyamines reduce the intestinal mucus layer, which subsequently facilitates the formation of abnormal α-synuclein fibrils in the intestinal neural plexus in PD, and also cause neuroinflammation in PD.

Citing Articles

The Inflammatory Mechanism of Parkinson's Disease: Gut Microbiota Metabolites Affect the Development of the Disease Through the Gut-Brain Axis.

Gao A, Lv J, Su Y Brain Sci. 2025; 15(2).

PMID: 40002492 PMC: 11853208. DOI: 10.3390/brainsci15020159.

Biofilm-associated proteins: from the gut biofilms to neurodegeneration.

Valle J Gut Microbes. 2025; 17(1):2461721.

PMID: 39898557 PMC: 11792866. DOI: 10.1080/19490976.2025.2461721.

The Role of the Gastrointestinal Microbiota in Parkinson's Disease.

Gabrielli M, Zileri Dal Verme L, Zocco M, Nista E, Ojetti V, Gasbarrini A Biomolecules. 2025; 15(1).

PMID: 39858421 PMC: 11764295. DOI: 10.3390/biom15010026.

Microbiome-based therapeutics for Parkinson's disease.

Hamilton A, Krout I, White A, Sampson T Neurotherapeutics. 2024; 21(6):e00462.

PMID: 39393983 PMC: 11585879. DOI: 10.1016/j.neurot.2024.e00462.

References

Sedel F, Bernard D, Mock D, Tourbah A . Targeting demyelination and virtual hypoxia with high-dose biotin as a treatment for progressive multiple sclerosis. Neuropharmacology. 2015; 110(Pt B):644-653. DOI: 10.1016/j.neuropharm.2015.08.028. View

Sedel F, Papeix C, Bellanger A, Touitou V, Lebrun-Frenay C, Galanaud D . High doses of biotin in chronic progressive multiple sclerosis: a pilot study. Mult Scler Relat Disord. 2015; 4(2):159-69. DOI: 10.1016/j.msard.2015.01.005. View

Nishiwaki H, Ito M, Negishi S, Sobue S, Ichihara M, Ohno K . Molecular hydrogen upregulates heat shock response and collagen biosynthesis, and downregulates cell cycles: meta-analyses of gene expression profiles. Free Radic Res. 2018; 52(4):434-445. DOI: 10.1080/10715762.2018.1439166. View

Hasegawa S, Goto S, Tsuji H, Okuno T, Asahara T, Nomoto K . Intestinal Dysbiosis and Lowered Serum Lipopolysaccharide-Binding Protein in Parkinson's Disease. PLoS One. 2015; 10(11):e0142164. PMC: 4634857. DOI: 10.1371/journal.pone.0142164. View

Ma S, Shungin D, Mallick H, Schirmer M, Nguyen L, Kolde R . Population structure discovery in meta-analyzed microbial communities and inflammatory bowel disease using MMUPHin. Genome Biol. 2022; 23(1):208. PMC: 9531436. DOI: 10.1186/s13059-022-02753-4. View

Svensson E, Horvath-Puho E, Thomsen R, Djurhuus J, Pedersen L, Borghammer P . Vagotomy and subsequent risk of Parkinson's disease. Ann Neurol. 2015; 78(4):522-9. DOI: 10.1002/ana.24448. View

Scheperjans F, Aho V, Pereira P, Koskinen K, Paulin L, Pekkonen E . Gut microbiota are related to Parkinson's disease and clinical phenotype. Mov Disord. 2014; 30(3):350-8. DOI: 10.1002/mds.26069. View

Palacios N, Wilkinson J, Bjornevik K, Schwarzschild M, McIver L, Ascherio A . Metagenomics of the Gut Microbiome in Parkinson's Disease: Prodromal Changes. Ann Neurol. 2023; 94(3):486-501. PMC: 10538421. DOI: 10.1002/ana.26719. View

Portincasa P, Bonfrate L, Vacca M, De Angelis M, Farella I, Lanza E . Gut Microbiota and Short Chain Fatty Acids: Implications in Glucose Homeostasis. Int J Mol Sci. 2022; 23(3). PMC: 8835596. DOI: 10.3390/ijms23031105. View

10.

Jungert A, McNulty H, Hoey L, Ward M, Strain J, Hughes C . Riboflavin Is an Important Determinant of Vitamin B-6 Status in Healthy Adults. J Nutr. 2020; 150(10):2699-2706. DOI: 10.1093/jn/nxaa225. View

11.

Orecchioni M, Ghosheh Y, Pramod A, Ley K . Macrophage Polarization: Different Gene Signatures in M1(LPS+) vs. Classically and M2(LPS-) vs. Alternatively Activated Macrophages. Front Immunol. 2019; 10:1084. PMC: 6543837. DOI: 10.3389/fimmu.2019.01084. View

12.

Nishiwaki H, Ito M, Hamaguchi T, Maeda T, Kashihara K, Tsuboi Y . Short chain fatty acids-producing and mucin-degrading intestinal bacteria predict the progression of early Parkinson's disease. NPJ Parkinsons Dis. 2022; 8(1):65. PMC: 9160257. DOI: 10.1038/s41531-022-00328-5. View

13.

Caspi R, Altman T, Billington R, Dreher K, Foerster H, Fulcher C . The MetaCyc database of metabolic pathways and enzymes and the BioCyc collection of Pathway/Genome Databases. Nucleic Acids Res. 2013; 42(Database issue):D459-71. PMC: 3964957. DOI: 10.1093/nar/gkt1103. View

14.

Boktor J, Sharon G, Verhagen Metman L, Hall D, Engen P, Zreloff Z . Integrated Multi-Cohort Analysis of the Parkinson's Disease Gut Metagenome. Mov Disord. 2023; 38(3):399-409. DOI: 10.1002/mds.29300. View

15.

Kuroishi T . Regulation of immunological and inflammatory functions by biotin. Can J Physiol Pharmacol. 2015; 93(12):1091-6. DOI: 10.1139/cjpp-2014-0460. View

16.

Ji J, Shu D, Zheng M, Wang J, Luo C, Wang Y . Microbial metabolite butyrate facilitates M2 macrophage polarization and function. Sci Rep. 2016; 6:24838. PMC: 4837405. DOI: 10.1038/srep24838. View

17.

Unger M, Spiegel J, Dillmann K, Grundmann D, Philippeit H, Burmann J . Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls. Parkinsonism Relat Disord. 2016; 32:66-72. DOI: 10.1016/j.parkreldis.2016.08.019. View

18.

Ueyama J, Hayashi M, Hirayama M, Nishiwaki H, Ito M, Saito I . Effects of Pesticide Intake on Gut Microbiota and Metabolites in Healthy Adults. Int J Environ Res Public Health. 2023; 20(1). PMC: 9819155. DOI: 10.3390/ijerph20010213. View

19.

Islam M, Azim F, Saju H, Zargaran A, Shirzad M, Kamal M . Pesticides and Parkinson's disease: Current and future perspective. J Chem Neuroanat. 2021; 115:101966. DOI: 10.1016/j.jchemneu.2021.101966. View

20.

Smith P, Howitt M, Panikov N, Michaud M, Gallini C, Bohlooly-Y M . The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science. 2013; 341(6145):569-73. PMC: 3807819. DOI: 10.1126/science.1241165. View